News items related to: Call to action
-
Why the World Can’t Trust Pharmaceutical Companies to Ensure Global Access to Essential Medicines
ITPC Global’s reaction to Gilead’s voluntary licence on lenacapravir: Gilead’s announcement of their voluntary license for lenacapavir—a groundbreaking, long-acting HIV...
-
HIV Community-Based Organizations are Fighting Patent Monopolies on Lenacapavir
Despite the world’s efforts, there have been over a million new cases of HIV each year. Lenacapavir (LEN), a long-acting...
-
ITPC Sounds Alarm to Prevent Mpox Treatment Disparities as WHO Declares Global Health Emergency
July 15, 2024 — ITPC Global welcomes the World Health Organization’s (WHO) declaration of the current mpox upsurge as a Public...
-
Activists at AIDS2024 called on ViiV Healthcare to drop their case in Colombia against Compulsory License on Dolutegravir
On the 24th of July, hundreds of treatment advocates attending AIDS2024 in Munich protested against the companies with “Drop The...
-
People’s Resolution: A Roadmap to Protect the Right to Life in a Failed Multilateral Order
We, as members of communities, civil society and activists affected by epidemics, call for a plan of action to end...
-
J & J’s Deal With the Global Drug Facility Disguises the Continued Issue with Access to Bedaquiline to Treat Drug-Resistant Tuberculosis
“This deal is big step backwards for global public health – it allows J & J to keep selling higher-priced...
-
Activists Across the World Demand Urgent Action to Improve Access to Lifesaving Tuberculosis (TB) Medicine, Bedaquiline
July 1, 2022 – A new generic version of bedaquiline produced by Macleods Pharmaceuticals in India has cleared the Global...
-
COVID-19 Pandemic: Bolsonaro and the Pharmaceutical Industry Are United Against Access to Medicines in Brazil
A new chapter of Bolsonaro’s deliberate strategy to spread the coronavirus has begun. This time, his government is partnering with...
-
World Health Day petition: No profit on pandemic!
Nine out of 10 people in low and middle income countries won’t have access to a COVID-19 vaccine in 2021....
-
Russian government advised – “issue compulsory license to make generic COVID-19 drug available”
First civil society, and now a generic drug company, have asked the Russian government to issue a compulsory license on...
-
HIV: Switch to generic darunavir in Kyrgyzstan and save $53,000
First published by the Partnership Network Association in Kyrgyzstan, read here in Russian. Analysis carried out by our campaign partner,...
-
Russian patient organizations ask Gilead to disclaim patents for Truvada
On 3 September 2020, 25 patient organizations working within the HIV response in Russia published an open letter to Gilead...